NANAIMO, B.C – Immediately, Tilray, Inc. (NASDAQ:TLRY), a world pioneer in cannabis manufacturing, analysis, cultivation and distribution, broadcasts the growth of its European management staff with the appointment of Arne Wilkens as Vice President, Enterprise Enlargement, Europe; José Tempero as Medical Affairs Director, Europe; Maike Gerlach as Vice President, Advertising and marketing, Europe; and Nadja Frenzel as Vice President, Business Growth, Europe. As well as, Natalie Bucceri joins Tilray’s worldwide staff as Director, International Portfolio Enlargement.
“Having sturdy individuals on our staff is vital to our success and progress,” says Sascha Mielcarek, Tilray’s Managing Director of Europe. “We’re thrilled to welcome this group of extremely expert leaders to our staff. Arne, José, Maike, Nadja and Natalie all be a part of Tilray with wide-ranging expertise in regulated industries. We’re assured their appointments will speed up our international progress technique and assist strengthen our place in Europe and different worldwide markets.”
The brand new senior appointments will work collaboratively with Tilray’s sturdy staff of specialists throughout the globe to speed up the corporate’s aggressive European and worldwide growth technique. Tilray’s multi-faceted EU Campus in Portugal, which lately obtained its manufacturing license and Good Manufacturing Practices (GMP) certification, will function the first hub for the cultivation, processing, analysis and distribution of branded Tilray merchandise all through Europe and different worldwide markets.
The current Tilray management appointments in Europe embrace:
- Arne Wilkens, VP, Enterprise Enlargement, Europe, brings 14 years of expertise throughout the pharmaceutical and biotech industries primarily in enterprise development-related features. In his most up-to-date position, Arne labored at AiCuris Anti-infective Cures GmbH the place he served as Director of Enterprise Growth and Alliance Administration overseeing all associate actions, market analytics, industrial evaluations and exterior partnerships. Wilkens graduated from Otto-von-Guericke College with a grasp’s diploma in administration.
- José Tempero, Medical Affairs Director, Europe, involves Tilray with 11 years of expertise within the pharmaceutical trade bringing experience in medical affairs and market entry. Most lately, Tempero led the product-based international medical affairs technique at Grünenthal GmbH. Tempero is professionally skilled as a pharmacist and holds his Grasp of Science in public well being.
- Maike Gerlach, VP, Advertising and marketing, Europe, joins Tilray from Grünenthal GmbH the place she was the Affiliate Director of Integration Advertising and marketing accountable for managing the worldwide integration of Zomig®, which was acquired from Astra Zeneca. Throughout her time on this position, Gerlach efficiently constructed and executed the model’s international strategic advertising plan. Gerlach involves Tilray with 17 years of promoting expertise within the pharmaceutical trade.
- Nadja Frenzel, VP, Business Growth, Europe, additionally involves Tilray from Grünenthal GmbH the place she contributed to the worldwide industrial technique on the International Business Management staff and established a brand new, aggressive, industrial mannequin throughout the advertising, medical, market entry and industrial excellence departments. Frenzel holds a Grasp of Science in well being coverage, economics and administration from Maastricht College within the Netherlands.
Tilray has a pioneering monitor report as an organization dedicated to creating pharmaceutical-grade medical cannabis merchandise accessible to sufferers in want everywhere in the world. Tilray has already efficiently exported inside Europe to the Czech Republic, Germany, the UK, Cyprus and Croatia and out of doors Europe to Argentina, Chile, america, South Africa, Australia and New Zealand. Tilray intends to launch extra merchandise in new markets throughout Europe and world wide because it continues to increase.
As part of Tilray’s worldwide growth, the corporate has additionally appointed Natalie Bucceri as Director, International Portfolio Enlargement. Bucceri most lately served as a part of group technique for Diageo, main initiatives to develop and implement short-term funding trade-offs and long-term strategic initiatives. Previous to working at Diageo, Natalie supported the Merck & Co Asia Pacific government staff on core strategic and business-development initiatives. Bucceri’s skilled expertise spans Europe, america, Asia, Australia and New Zealand. Bucceri might be based mostly out of the U.Ok. and can work immediately with the worldwide growth staff, with an instantaneous concentrate on the European market.